117 related articles for article (PubMed ID: 20813208)
1. Development of novel nanoparticles shelled with heparin for berberine delivery to treat Helicobacter pylori.
Chang CH; Huang WY; Lai CH; Hsu YM; Yao YH; Chen TY; Wu JY; Peng SF; Lin YH
Acta Biomater; 2011 Feb; 7(2):593-603. PubMed ID: 20813208
[TBL] [Abstract][Full Text] [Related]
2. Berberine-loaded targeted nanoparticles as specific Helicobacter pylori eradication therapy: in vitro and in vivo study.
Lin YH; Lin JH; Chou SC; Chang SJ; Chung CC; Chen YS; Chang CH
Nanomedicine (Lond); 2015 Jan; 10(1):57-71. PubMed ID: 25177920
[TBL] [Abstract][Full Text] [Related]
3. Genipin-cross-linked fucose-chitosan/heparin nanoparticles for the eradication of Helicobacter pylori.
Lin YH; Tsai SC; Lai CH; Lee CH; He ZS; Tseng GC
Biomaterials; 2013 Jun; 34(18):4466-79. PubMed ID: 23499480
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles incorporated in pH-sensitive hydrogels as amoxicillin delivery for eradication of Helicobacter pylori.
Chang CH; Lin YH; Yeh CL; Chen YC; Chiou SF; Hsu YM; Chen YS; Wang CC
Biomacromolecules; 2010 Jan; 11(1):133-42. PubMed ID: 19924885
[TBL] [Abstract][Full Text] [Related]
5. Novel protein-loaded chondroitin sulfate-chitosan nanoparticles: preparation and characterization.
Yeh MK; Cheng KM; Hu CS; Huang YC; Young JJ
Acta Biomater; 2011 Oct; 7(10):3804-12. PubMed ID: 21742066
[TBL] [Abstract][Full Text] [Related]
6. Amoxicillin, clarithromycin, and omeprazole based targeted nanoparticles for the treatment of H. pylori.
Ramteke S; Ganesh N; Bhattacharya S; Jain NK
J Drug Target; 2009 Apr; 17(3):225-34. PubMed ID: 19241256
[TBL] [Abstract][Full Text] [Related]
7. Development of pH-responsive chitosan/heparin nanoparticles for stomach-specific anti-Helicobacter pylori therapy.
Lin YH; Chang CH; Wu YS; Hsu YM; Chiou SF; Chen YJ
Biomaterials; 2009 Jul; 30(19):3332-42. PubMed ID: 19299008
[TBL] [Abstract][Full Text] [Related]
8. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
Liu Z; Jiao Y; Liu F; Zhang Z
J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
[TBL] [Abstract][Full Text] [Related]
9. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori.
Luo M; Jia YY; Jing ZW; Li C; Zhou SY; Mei QB; Zhang BL
Colloids Surf B Biointerfaces; 2018 Apr; 164():11-19. PubMed ID: 29367052
[TBL] [Abstract][Full Text] [Related]
10. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori.
Jing ZW; Jia YY; Wan N; Luo M; Huan ML; Kang TB; Zhou SY; Zhang BL
Biomaterials; 2016 Apr; 84():276-285. PubMed ID: 26851392
[TBL] [Abstract][Full Text] [Related]
12. In vitro inhibition of Helicobacter pylori growth and adherence to gastric mucosal cells by Pycnogenol.
Rohdewald P; Beil W
Phytother Res; 2008 May; 22(5):685-8. PubMed ID: 18350522
[TBL] [Abstract][Full Text] [Related]
13. Effect of gastric environment on Helicobacter pylori adhesion to a mucoadhesive polymer.
Nogueira F; Gonçalves IC; Martins MC
Acta Biomater; 2013 Feb; 9(2):5208-15. PubMed ID: 22995406
[TBL] [Abstract][Full Text] [Related]
14. Heparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin.
Tang DW; Yu SH; Ho YC; Mi FL; Kuo PL; Sung HW
Biomaterials; 2010 Dec; 31(35):9320-32. PubMed ID: 20863557
[TBL] [Abstract][Full Text] [Related]
15. Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori.
Umamaheshwari RB; Jain S; Bhadra D; Jain NK
J Pharm Pharmacol; 2003 Dec; 55(12):1607-13. PubMed ID: 14738585
[TBL] [Abstract][Full Text] [Related]
16. Dendritic effect of ligand-coated nanoparticles: enhanced apoptotic activity of silica-berberine nanoconjugates.
Halimani M; Chandran SP; Kashyap S; Jadhav VM; Prasad BL; Hotha S; Maiti S
Langmuir; 2009 Feb; 25(4):2339-47. PubMed ID: 19146398
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-lignosulfonates sono-chemically prepared nanoparticles: characterisation and potential applications.
Kim S; Fernandes MM; Matamá T; Loureiro A; Gomes AC; Cavaco-Paulo A
Colloids Surf B Biointerfaces; 2013 Mar; 103():1-8. PubMed ID: 23178385
[TBL] [Abstract][Full Text] [Related]
18. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin.
Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ
Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924
[TBL] [Abstract][Full Text] [Related]
19. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori.
Arif M; Dong QJ; Raja MA; Zeenat S; Chi Z; Liu CG
Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():17-24. PubMed ID: 29208276
[TBL] [Abstract][Full Text] [Related]
20. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
